• C-MER Medical posted 1H 2026 profit attributable to equity holders of HK$ 50.02 million, up 0.2%, as revenue rose 8.5% to HK$ 1.02 billion.
• Basic earnings per share edged up to 4.21 HK cents from 4.11 HK cents.
• Gross profit climbed 10% to HK$ 323.36 million, lifting gross margin by 0.5 percentage points to 31.6%.
• Non-HKFRS adjusted profit attributable to equity holders fell 5.2% to HK$ 65.99 million, reflecting losses in Mainland China other business.
• Mainland China ophthalmic segment returned to profit with HK$ 2.83 million; Mainland China dental segment profit rose to HK$ 44.19 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C-Mer Medical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260825-12297569), on August 25, 2026, and is solely responsible for the information contained therein.